Jean-Jacques Bertrand
Directeur/Membre du Conseil chez NEOVACS
Profil
Jean-Jacques Bertrand is currently the Chairman of the Canadian Network for Vaccines & Immunotherapeutics, Chairman of Viroxis SA, Vice Chairman of Brive Rugby SA, Director of Pierre Fabre Participations SAS, Director of Neovacs SA, and Venture Partner of Truffle Capital SAS.
He previously served as Chairman & Chief Executive Officer of Aventis Pasteur Sa, Chief Executive Officer of Rhone Poulenc Rorer, Chief Executive Officer of Aventis Pharma SARL, Chairman & Chief Executive Officer of Sanofi Pasteur, CEO-Pharmaceutical Operations of Rhône-Poulenc Santé, Chairman of Guerbet SA, Chairman-Supervisory Board of Pierre Fabre SA, Chairman-Supervisory Board of Cytheris SA, Chairman of Leem, Chairman of Fédération Françaises des Industries de Santé, Non-Executive Director of Muzicall Ltd., Director of B3G SA, Director of La Fondation pour la Recherche Médicale, and Independent Director of Abivax SA. He obtained his undergraduate degree from École des Hautes Études Commerciales de Paris.
Postes actifs de Jean-Jacques Bertrand
| Sociétés | Poste | Début |
|---|---|---|
| NEOVACS | Directeur/Membre du Conseil | - |
| Brive Rugby SA | Directeur/Membre du Conseil | - |
Pierre Fabre Participations SAS
 Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Pierre Fabre Participations SASU operates as a holding company, with interests in the manufacture of pharmaceutical products. The company is headquartered in Paris, France. | Directeur/Membre du Conseil | 25/08/2018 |
| Viroxis SA | Président | - |
| Canadian Network for Vaccines & Immunotherapeutics | Président | 28/06/2010 |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Analyste en capital-investissement | 17/12/2009 |
Anciens postes connus de Jean-Jacques Bertrand
| Sociétés | Poste | Fin |
|---|---|---|
| ABIVAX | Directeur/Membre du Conseil | 11/07/2023 |
B3G SA
 B3G SA Specialty TelecommunicationsCommunications B3G SA provides broadband telephone operating services. The firm offers b-initial, b-direct, b-centrex, and b-specific services. It serves Internet service providers, cable companies, regional operators, and telecommunication and multimedia professionals. It has operations in France, Italy, Great Britain, Belgium, Denmark, Bulgaria, Romania, and Turkey. The company was founded in 2001 and is headquartered in La Défense, France. | Directeur/Membre du Conseil | 30/10/2013 |
Muzicall Ltd.
 Muzicall Ltd. Wireless TelecommunicationsCommunications Muzicall Ltd. provides ringback tone services. It offers its services for mobile operators, corporates, charities, advertising and media companies. The firm offers ringback tone services for fun, business and advertisements. The company was founded in 2004 by Mark Collins and Richard Nigel Curzon Jackson and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 03/07/2013 |
| ░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jean-Jacques Bertrand
| École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NEOVACS | Health Technology |
| GUERBET | Health Technology |
| ABIVAX | Health Technology |
| Entreprise privées | 17 |
|---|---|
Cytheris SA
 Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France. | Health Technology |
Truffle Capital SAS
Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Finance |
Muzicall Ltd.
Muzicall Ltd. Wireless TelecommunicationsCommunications Muzicall Ltd. provides ringback tone services. It offers its services for mobile operators, corporates, charities, advertising and media companies. The firm offers ringback tone services for fun, business and advertisements. The company was founded in 2004 by Mark Collins and Richard Nigel Curzon Jackson and is headquartered in London, the United Kingdom. | Communications |
| Canadian Network for Vaccines & Immunotherapeutics | |
| La Fondation pour la Recherche Médicale | |
B3G SA
B3G SA Specialty TelecommunicationsCommunications B3G SA provides broadband telephone operating services. The firm offers b-initial, b-direct, b-centrex, and b-specific services. It serves Internet service providers, cable companies, regional operators, and telecommunication and multimedia professionals. It has operations in France, Italy, Great Britain, Belgium, Denmark, Bulgaria, Romania, and Turkey. The company was founded in 2001 and is headquartered in La Défense, France. | Communications |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
| Rhône-Poulenc Santé | |
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the company is based in Antony, France. | Health Technology |
| Brive Rugby SA | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
| Viroxis SA | |
| Leem | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
Pierre Fabre Participations SAS
Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Pierre Fabre Participations SASU operates as a holding company, with interests in the manufacture of pharmaceutical products. The company is headquartered in Paris, France. | Health Technology |
| Aventis Pasteur Sa | Health Technology |
| Fédération Françaises des Industries de Santé |
